📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOMECOVERAGEBEAM › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$BEAM
BEAM Earnings: Beat 3/4 · 4 quarters tracked
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
TOTAL VIEWS
5
◈ EARNINGS HUB · 2026-03

BEAM Earnings: Beat, Surprise History & Forecast

3/4 quarters beaten · Last EPS $-0.91 (+18.4%) · AI Grade: HIGH
◈ ESEN AI · EARNINGS PREVIEW
BEAM reported EPS of $-0.91 in its most recent quarter (2026-03), beating consensus estimate of $-1.12 by +18.4%. Over the last 4 quarters, the company has beaten estimates 3 times (75% beat rate) with an average surprise of +29.0%. ESEN AI grade: HIGH.
LAST EPS
$-0.91
est $-1.12
LAST SURPRISE
+18.4%
2026-03
BEAT RATE
3/4
beats / quarters
AVG SURPRISE
+29.0%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-03-31
$-0.91
$-1.12
+18.4%
2025-12-31
$-0.10
$-1.01
+89.8%
2025-09-30
$-1.10
$-1.06
-3.7%
2025-06-30
$-1.00
$-1.13
+11.7%
◈ RELATED EARNINGS NEWS
manilatimes.
2026-07-08
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
NEUTRAL
seekingalpha
2026-06-26
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM)
NEUTRAL
insidermonke
2026-06-16
Is Beam Therapeutics Inc. (BEAM) One of the Best Genomics Stocks to Buy According to Analysts?
NEUTRAL
View all BEAM news →
◈ FREQUENTLY ASKED QUESTIONS
When did $BEAM last report earnings?
BEAM last reported earnings on 2026-03-31, with actual EPS of $-0.91 vs estimate of $-1.12.
Did $BEAM beat earnings estimates?
Yes, BEAM beat consensus EPS by +18.4% in its most recent quarter.
What is $BEAM's earnings beat rate?
BEAM has beaten consensus EPS in 3 of 4 quarters (75%). Average surprise: +29.0%.
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice